PIK3CD and neoplasm: We showed that AZD8186 exerted its anti‐tumor function in vitro due to PI3Kβ inhibition, since PTEN‐null TNBC cells do not express appreciable levels of p110δ and the specific inhibition of p110α in combination with EGFR did not produce the same effects.